(Q38528072)

3 September 2017

Protease inhibitor-induced lipodystrophy (English)

1 reference

3 September 2017

Williamson K

1

1 reference

3 September 2017

Reboli AC

series ordinal

2

1 reference

3 September 2017

Manders SM

series ordinal

3

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 April 1999

1 reference

Journal of the American Academy of Dermatology

3 September 2017

1 reference

3 September 2017

40

1 reference

3 September 2017

635-636

1 reference

3 September 2017

4

1 reference

Visceral abdominal-fat accumulation associated with use of indinavir

3 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970452-4

7 January 2021

Development of cervical fat pads following therapy with human immunodeficiency virus type 1 protease inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970452-4

7 January 2021

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970452-4

7 January 2021

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970452-4

7 January 2021

Localized adipose tissue hypertrophy in patients receiving human immunodeficiency virus protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970452-4

7 January 2021

Indinavir-associated lipodystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970452-4

7 January 2021

Pseudo-Cushing's syndrome in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970452-4

7 January 2021

"Buffalo hump" in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970452-4

7 January 2021

"Buffalo hump" in men with HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970452-4

7 January 2021

A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970452-4

7 January 2021

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970452-4

7 January 2021

10.1016/S0190-9622(99)70452-4

Identifiers

DOI

1 reference

3 September 2017

1 reference